An observational study in Headache, sponsored by Cairo University. Not yet recruiting. Open to participants aged 20 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-02-06.
Sponsored by Cairo University · Observational
ARABIC VERSION OF HENRY FORD HOSPITAL HEADACHE DISABILITY INVENTORY QUESTIONNAIRE: CROSS-CULTURAL ADAPTATION, VALIDITY, AND RELIABILITY
This questionnaire will be developed to assess the impact of headache on functional and emotional aspects of daily life. The Alpha version of HDI (alpha-HDI) included 40 items, but the newest Beta version (beta-HDI) contains 25 items. The Beta version of HDI, developed by Jacobson (1994) in English, is a generic headache disability questionnaire widely administered in the related research studies.
This questionnaire measures the effect of different medical and rehabilitation treatments on the physical and emotional disabilities in patients with different types of headaches. This generic headache questionnaire is not specific to any headache type. Therefore, HDI will be applied to follow the general consequences of different headache types and to compare different aspects of disability for a variety of headaches. Based on the literature, the original HDI has strong internal consistency/reliability and construct validity. The results of test-retest showed that HDI has an acceptable level of reliability considering the total questionnaire and its subscale scores.
The validity and reliability of the non-English versions of HDI, such as Spanish, have been previously investigated and confirmed. The Arabic researchers and practitioners need valid and reliable tools to measure the emotional and functional states of patients with different headache disorders.
So, This study will be carried out to translate and culturally adapt the HDI questionnaire for administration among the Egyptian patients with headaches. Moreover, This study will assess the validity and reliability of the developed Arabic version of this questionnaire. Creation of questionnaires in different languages must pass through many steps. Questionnaires must be translated, then culturally adapted to the environment in which they will be used.
1,226 studies on the registry are indexed under Headache; 202 are open to participants now.
This study's planned enrollment of 250 is above the median of 120 across 257 observational studies indexed under Headache.
Browse Headache studies →Cairo University is the lead sponsor of 4,780 studies on the registry; 1,427 are open to participants now.
Of its 36 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.
Counted across the registry records on this site, refreshed daily.
In order to select the participants, researchers will examine the patients who referred to the hospital over a 3-month period and selected those diagnosed with chronic primary headache to enter the study.
Exclusion Criteria:
Arabic Version Of Henry Ford Hospital Headache Disability Inventory Questionnaire : Cross Cultural Adaptation, Validity, And Reliabilit
Other: questionnaire
questionnaire
Arabic Version Of Henry Ford Hospital Headache Disability Inventory Questionnaire : Cross Cultural Adaptation, Validity, And Reliability
This study will be carried out to translate and culturally adapt the Henry ford inventory questionnaire for administration among the Egyptian patients with headaches.
Time frame: 4 month
Arabic Version Of Henry Ford Hospital Headache Disability Inventory Questionnaire : Cross Cultural Adaptation, Validity, And Reliability
This study will assess the validity and reliability of the developed Arabic version of this questionnaire.
Time frame: 4 month
No study locations are listed for this record.
This study is not yet recruiting, as verified in Feb 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Cairo University